Data as of Q4 2025 (Dec 31, 2025)·Next filing deadline: May 15, 2026

Telix Pharmaceuticals Limited

Name: SEC 13F Institutional Holdings Database
Creator: HedgeTrack.ai
License: https://www.sec.gov/privacy.htm

(TLX)

Financial Statements · SEC EDGAR XBRL

Source: SEC EDGAR XBRL

No data available for this statement.